Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 22.49
+0.11 (0.49%)
Feb 4, 2026, 3:00 PM CST
SHA:603716 Revenue
Thalys Medical Technology Group had revenue of 273.70M CNY in the quarter ending September 30, 2025, a decrease of -38.41%. This brings the company's revenue in the last twelve months to 1.25B, down -34.22% year-over-year. In the year 2024, Thalys Medical Technology Group had annual revenue of 1.81B, down -9.74%.
Revenue (ttm)
1.25B
Revenue Growth
-34.22%
P/S Ratio
3.70
Revenue / Employee
1.00M
Employees
1,246
Market Cap
4.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.81B | -195.45M | -9.74% |
| Dec 31, 2023 | 2.01B | -302.50M | -13.10% |
| Dec 31, 2022 | 2.31B | -290.92M | -11.19% |
| Dec 31, 2021 | 2.60B | 474.08M | 22.30% |
| Dec 31, 2020 | 2.13B | 294.70M | 16.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 7.40B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Medicalsystem Biotechnology | 1.47B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Amoy Diagnostics | 1.13B |
| Berry Genomics Co.,Ltd | 941.16M |
| SMO ClinPlus CO.,LTD. | 819.09M |